Clinical trials
Hormones clinical trials
Below are recruiting hormones clinical trials, each written for real people, not researchers. We’re tracking 423 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05352178RecruitingPhase 3
Targeted treatment for few-spread prostate cancer spots
This Phase 3 trial tests whether treating only a small number of prostate cancer metastases can help people with “oligorecurrent” (limited repeat) prostate cancer. It may reduce cancer activity while avoiding broader whole-body treatment for some patients.
LeuvenAges 18 years+ - NCT07812831Enrolling by invitation
How health information changes over time
This study looks at how health information from people changes over time. The goal is to better understand normal patterns and spot when things change, which may help doctors improve care. You can join whether you have a medical condition or are generally healthy.
New York, New YorkAges 18 years+ - NCT06495983Recruiting
Hormone tracking and data collection in primary aldosteronism
This study tracks hormone levels and collects different health information to better understand primary aldosteronism, a condition where your adrenal glands produce too much aldosterone. It aims to improve diagnosis and care.
BergenAges 18–70 - NCT07801105Recruiting
Hormone-free egg collection for storing embryos
This study tests a new way to collect eggs without using fertility hormones, then fertilize them and freeze the embryos for later transfer. It may help women who want to avoid hormone injections, but it requires several monitoring visits and specific health criteria.
Bedford, TexasAges 18–35 - NCT06413381Recruiting
Endometriosis hormone therapy: who may not respond
This study looks for reasons why some people with endometriosis don't get pain relief from hormone medications. It aims to find out who might need a different treatment approach.
Bologna, BOAges 18–50 - NCT06544473RecruitingPhase 4
Estrogen pill vs. patch for Turner syndrome
This trial compares oral and transdermal (patch) estrogen to find the right dose for women with Turner syndrome. It aims to see which method works best for hormone replacement.
Aarhus, Aarhus NAges 18–50 - NCT06566066Recruiting
Thyroid hormone resistance patient registry
This study creates a registry for people with thyroid hormone resistance caused by specific genetic mutations. It helps doctors collect data to better understand and treat the condition.
BerlinAges Any age - NCT06570460RecruitingPhase 4
Estrogen pills vs. patch for Turner syndrome
This study compares two ways of taking estrogen (pills or a skin patch) in women with Turner syndrome to see which works better over time. It also includes healthy women for comparison.
Aarhus, Aarhus NAges 18–50 - NCT07764328Recruiting
Supplement for hormone balance in women with PCOS
This trial tests a dietary supplement designed to improve hormone balance in women with PCOS or PCOS-like symptoms. It may help regulate menstrual cycles and reduce signs like acne or excess hair growth.
Los Angeles, CaliforniaAges 18–40 - NCT07762287RecruitingPhase 1
How two forms of elinzanetant are processed in healthy women
This study looks at how the body handles two different forms of a drug called elinzanetant in healthy women. It helps doctors understand the drug's effects and may guide future treatment options.
Mount Royal, QuebecAges 18–65 - NCT02081924Recruiting
Testing kisspeptin hormone delivery and blood hormone changes
This study gives the hormone kisspeptin over time and measures how your body’s reproductive hormones respond. It may help researchers understand how reproductive hormone signals work, which could guide future treatments.
LondonAges 18–60 - NCT06587477Recruiting
Fertility in Men Who Had Cancer as Children
This study examines testicular function and semen quality in men who were treated for cancer before age 18 and are now in remission. It aims to understand how childhood cancer treatments affect long-term fertility.
Hong KongAges 18–50 - NCT07743944Recruiting
Breast cancer second-line treatment patterns in China
This study looks at how doctors in China treat hormone receptor-positive, HER2-negative breast cancer that has spread, when patients are starting their second line of therapy. The goal is to learn more about real-world treatment patterns and results, which may help you and your doctor make more informed treatment decisions.
Nanjing, JiangsuAges 18 years+ - NCT07747909Recruiting
Orlistat for metabolic and hormonal health in PCOS
This study tests whether the weight-loss drug orlistat can improve blood sugar, hormones, and other metabolic measures in women with polycystic ovary syndrome (PCOS). If you have PCOS and are overweight, this treatment might help with symptoms like irregular periods and excess hair growth.
Abbottābād, Khyber PakhtunkhwaAges 18–45 - NCT07742488Recruiting
Statins and hormone therapy for cholesterol in menopause
This study looks at whether taking statins (cholesterol-lowering medicine) along with hormone replacement therapy (HRT) affects blood clotting in women going through menopause who have high cholesterol. It may help doctors understand how these medicines work together.
Pisa, ItalyAges 45–55 - NCT07737951Recruiting
Tai chi for joint pain from breast cancer hormone therapy
This trial tests whether tai chi can help reduce joint pain caused by aromatase inhibitors, which are hormone therapies for breast cancer. If you have joint pain from this treatment, tai chi might be a gentle way to find relief.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05594095RecruitingPhase 2
Study for advanced ER+ HER2− breast cancer after CDK4/6 therapy
This Phase 2 trial tests an investigational “SNF platform” treatment for advanced ER+ (estrogen-receptor positive) and HER2− breast cancer in people who already tried CDK4/6 inhibitor therapy. It may help shrink tumors and improve outcomes for cancers that have come back or spread.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07708194RecruitingPhase 1/Phase 2
Entinostat plus pyrotinib and hormone therapy for advanced breast cancer
This trial tests a new combination of two targeted drugs (entinostat and pyrotinib) with hormone therapy for people with advanced, triple-positive breast cancer whose disease has progressed after trastuzumab (Herceptin). The goal is to see if this approach works better than current options.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT07701863Recruiting
Vaginal dryness treatment study
This study tests a new treatment (F-GYN) to help with vaginal dryness and pain during sex. It aims to see if the treatment improves moisture and reduces discomfort.
BolesławiceAges 18 years+ - NCT07704658RecruitingPhase 4
Pralsetinib drug interaction study for advanced solid tumors
This trial tests how pralsetinib interacts with other drugs in people with advanced solid tumors that have a specific RET gene change. It aims to find the right dose and safety profile.
Logroño, La RiojaAges 18 years+ - NCT07705334RecruitingPhase 1
Study of SHY-ONC6 for advanced solid tumors
This trial tests a new drug called SHY-ONC6 that targets and breaks down cancer cells. It's for people with advanced solid tumors that haven't responded to standard treatments.
Scottsdale, ArizonaAges 18 years+ - NCT07701941RecruitingPhase 1/Phase 2
Combination treatment for advanced breast cancer
This trial tests two targeted drugs together for people with advanced breast cancer that is hormone receptor positive and has low levels of a protein called HER2. The goal is to see if this combination helps shrink tumors or slow the cancer's growth.
Los Angeles, CaliforniaAges 18 years+ - NCT07696351RecruitingPhase 4
Ultrasound-guided endometrial preparation for endometriosis
This trial tests whether a 2-3 month hormone treatment before a frozen embryo transfer improves pregnancy success in women with deep endometriosis. It may help your body prepare better for the embryo.
Nanjing, JiangsuAges 18–39 - NCT07687589Enrolling by invitation
Testing a gut hormone for nausea in healthy adults
This study tests whether a natural gut hormone called GIP can reduce nausea by increasing blood flow to the gut. Researchers want to see how this works in healthy people.
HellerupAges 18–60
Hear when a new Hormones trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hormones?
- Yes. Clin2 currently lists 423 recruiting hormones studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hormones trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hormones trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.